You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

capivasertib

Showing 1 - 16 of 16
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Solid Tumours Trial in Shanghai (Capivasertib, Paclitaxel)

Completed
  • Advanced Solid Tumours
  • Shanghai, China
    Research Site
Aug 18, 2022

Premenopausal Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Taipei City (Goserelin, Fulvestrant,

Recruiting
  • Premenopausal Breast Cancer
  • +2 more
  • Taipei City, Taiwan
    Department of Oncology, National Taiwan University Hospital
Feb 7, 2023

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Capivasertib
  • abiraterone acetate
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Solid and Hematological Malignancies Trial in Berlin (Capivasertib, Rabeprazole)

Completed
  • Solid and Hematological Malignancies
  • Berlin, Germany
    Research Site
May 6, 2022

Solid Tumour Trial in United States (Capivasertib, Midazolam)

Recruiting
  • Solid Tumour
  • West Hollywood, California
  • +9 more
Aug 22, 2022

Prostate Cancer Trial in Spain, United States (Capivasertib, Enzalutamide, Abiraterone)

Completed
  • Prostate Cancer
  • Capivasertib
  • +2 more
  • Indianapolis, Indiana
  • +5 more
Jul 11, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Triple-Negative Breast Carcinoma Trial in Portland (procedure, drug,

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • Metastatic Triple-Negative Breast Carcinoma
  • Biopsy
  • +6 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 29, 2022

Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Capivasertib, Matched Capivasertib Placebo,

Recruiting
  • Locally Advanced (Inoperable) or Metastatic Breast Cancer
  • Capivasertib
  • +3 more
  • Los Angeles, California
  • +76 more
Nov 25, 2022

Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive

Completed
  • Healthy Volunteers (Intended Indication: Metastatic Patients With Triple Negative or HR+ Breast Cancer, or Hormone Sensitive Prostate Cancer)
  • Berlin, Germany
    Research Site
Apr 8, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)

Active, not recruiting
Has Results
  • Advanced Lymphoma
  • +5 more
  • Capivasertib
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 28, 2022

Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, Capivasertib, Placebo)

Active, not recruiting
  • Locally Advanced (Inoperable) or Metastatic Breast Cancer
  • Gilbert, Arizona
  • +214 more
Feb 1, 2023

Prostate Cancer Trial in Worldwide (capivasertib, docetaxel, )

Recruiting
  • Prostate Cancer
  • capivasertib
  • +2 more
  • Phoenix, Arizona
  • +203 more
Jul 27, 2022

Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Endometrial Serous Adenocarcinoma Trial in United

Recruiting
  • Endometrial Undifferentiated Carcinoma
  • +6 more
  • Capivasertib
  • +4 more
  • Birmingham, Alabama
  • +741 more
Feb 2, 2023

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab deruxtecan, Durvalumab, Paclitaxel)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab deruxtecan
  • +6 more
  • Iowa City, Iowa
  • +60 more
Jan 3, 2023

Intracranial Meningioma, Recurrent Meningioma, NF2 Gene Mutation Trial in United States (Vismodegib, FAK Inhibitor GSK2256098,

Recruiting
  • Intracranial Meningioma
  • +2 more
  • Birmingham, Alabama
  • +707 more
Sep 25, 2022

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022